Lanreotide
Long-acting somatostatin receptor agonist analyzed for cellular proliferation suppression.
Open Lanreotide in the 3D analyzerAnalytical specification
| Empirical formula | C54H69N11O10S2 |
|---|---|
| Molecular weight | 1096.3 g/mol |
| Isoelectric point (pI) | 8.85 |
| Assay purity (HPLC) | 99.82% |
| Retention time | 5.10 min |
| Peak area / height | 12500 / 1020 |
| Reference batch | LA-2026-K10 |
| Research category | Immune, Solvents & Others |
| Amino-acid sequence | D-2Nal-C-Y-D-Trp-K-V-C-Thr-NH2 |
Research characteristics
Receptor Agonism
High affinity for SSTR2 and SSTR5
Oncology Target
Impedes divide of localized tumor cells
Extended Release
Fosters structured metabolic analysis
Pristine Assay
No synthetic side chain impurities
Reconstitution
Use the interactive reconstitution calculator to convert vial size (mg), bacteriostatic water volume (ml) and target dose (mcg) into a syringe draw on a standard 100-unit insulin syringe. Open the dosage calculator.
Related immune, solvents & others compounds
Tuftsin
Naturally occurring tetrapeptide phagocytosis-stimulating agent evaluated for immune defense.
Thymosin Alpha-1 (Immune)
Immunomodulating Thymosin Alpha-1 segment evaluated for systemic immune response optimization.
LL-37 (Immune Grade)
Cathelicidin immune segment researched for biofilm disruption and cellular pathogens defense.
KPV (Dermal & Immune)
Purified KPV tripeptide tailored for contact dermatitis and systemic cytokine balancing studies.
Thymopentin (Immune)
Thymopentin (TP-5) segment targeting lymphocyte maturation and cellular immune validation.
Splenopentin (SP-5)
Splenic peptide analog evaluated for T-cell subset balance and antibody optimization.